Seyed-Mohammad Fereshtehnejad

31PUBLICATIONS
54CO-AUTHORS
Medical infection agents (incl. prions)PharmacogenomicsTraditional Chinese medicine and treatmentsPeripheral nervous systemAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 10, 2026
Disease-Duration-Specific Percentiles for Prospective Subtyping of Parkinson's Disease: A PPMI-Based Study.

|May 04, 2026
Effectiveness and Tolerability of Pharmacologic Prophylaxis for Chronic Migraine : A Systematic Review of Randomized Controlled Trials.

|Apr 21, 2026
Effectiveness and tolerability of pharmacological prophylaxis in migraine patients with prior preventive treatment failure: A systematic review and network meta-analysis of randomized controlled trials.

|Mar 28, 2026
Skin-Based α-Synuclein Deposits Detection Across the Prodromal Continuum of Synucleinopathies: Updated Evidence and Perspectives.

Seyed-Mohammad Fereshtehnejad

|Jan 29, 2026
Faster reaction times of CSF alpha-synuclein seed amplification assay predict the diffuse malignant subtype of Parkinson's disease at 10-year follow-up.

Piergiorgio Grillo, Giulietta Maria Riboldi, Antonio Pisani

|Jan 28, 2026
Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay.

Sarah M Brooker, Jacopo Pasquini, Seung Ho Choi

Pageof 6

Frequent Collaborators

3 joint publications

Un Jung Kang

3 joint publications

Johan Lökk

2 joint publications

Piergiorgio Grillo

2 joint publications

Ghorban Taghizadeh